1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1797629814937485312 |
---|---|
author | Ankita Srivastava Arvin Akoopie Ranveer Jayani Jonah Rainey Tracy Charlton Omer Keinan Jacek Ostrowski |
author_facet | Ankita Srivastava Arvin Akoopie Ranveer Jayani Jonah Rainey Tracy Charlton Omer Keinan Jacek Ostrowski |
author_sort | Ankita Srivastava |
collection | DOAJ |
first_indexed | 2024-03-11T10:59:19Z |
format | Article |
id | doaj.art-8d268105a3294942a9831aee83e63bf2 |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-03-11T10:59:19Z |
publishDate | 2023-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-8d268105a3294942a9831aee83e63bf22023-11-12T20:25:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.11861186 Engineering bispecific dual-antagonist antibodies for novel cancer therapiesAnkita Srivastava0Arvin Akoopie1Ranveer Jayani2Jonah Rainey3Tracy Charlton4Omer Keinan5Jacek Ostrowski6Dermatology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India1AlivaMab Discovery Services, San Diego, CA, USA1AlivaMab Discovery Services, San Diego, CA, USA2Eli Lilly, Lilly Biotechnology Center, San Diego, CA, USA1AlivaMab Discovery Services, San Diego, CA, USA1AlivaMab Discovery Services, San Diego, CA, USA3Avidity Biosciences, San Diego, CA, USA |
spellingShingle | Ankita Srivastava Arvin Akoopie Ranveer Jayani Jonah Rainey Tracy Charlton Omer Keinan Jacek Ostrowski 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies Journal for ImmunoTherapy of Cancer |
title | 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies |
title_full | 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies |
title_fullStr | 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies |
title_full_unstemmed | 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies |
title_short | 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies |
title_sort | 1186 engineering bispecific dual antagonist antibodies for novel cancer therapies |
work_keys_str_mv | AT ankitasrivastava 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies AT arvinakoopie 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies AT ranveerjayani 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies AT jonahrainey 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies AT tracycharlton 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies AT omerkeinan 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies AT jacekostrowski 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies |